menu
    • menu

    Company profile for AOBiome Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AOBiome Therapeutics, Inc. is a Cambridge, MA-based life sciences company focused on transforming human health by developing microbiome-based therapies for local, nasal and systemic inflammatory conditions. Founded in 2012 by PatientsLikeMe founder Jamie Heywood and MIT-trained Chemical Engineer David Whitlock, AOBiome is advancing a pipeline of multiple, clinical-stage therapeutic candidates. The company's portfolio includes ...
    AOBiome Therapeutics, Inc. is a Cambridge, MA-based life sciences company focused on transforming human health by developing microbiome-based therapies for local, nasal and systemic inflammatory conditions. Founded in 2012 by PatientsLikeMe founder Jamie Heywood and MIT-trained Chemical Engineer David Whitlock, AOBiome is advancing a pipeline of multiple, clinical-stage therapeutic candidates. The company's portfolio includes multiple clinical-stage programs: a completed Phase 2 study to treat patients with acne vulgaris or acne, a Phase 1b study to treat patients with pediatric eczema (atopic dermatitis).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AOBiome TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    125 Cambridge Park Dr 5th Floor Cambridge, Massachusetts 02140
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aobiome.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aobiome
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Veristat, Aobiome to Present at Clinical Outsourcing Group
    Veristat, Aobiome to Present at Clinical Outsourcing Group

    07 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251007459013/en/Veristat-and-AOBiome-Therapeutics-to-Present-at-Clinical-Outsourcing-Group-on-Essential-Elements-of-Effective-Partnerships-with-CROs

    BUSINESSWIRE
    07 Oct 2025
    Share Share
    AOBiome announces the publication of positive Ph 2b results
    AOBiome announces the publication of positive Ph 2b results

    16 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aobiome-announces-the-publication-of-positive-phase-2b-results-in-the-lancets-eclinicalmedicine-for-b244-in-the-treatment-of-mild-to-moderate-atopic-dermatitis-and-moderate-to-severe-pruritus-301826082.html

    PR NEWSWIRE
    16 May 2023
    Share Share
    AOBiome Granted Composition of Matter Patent for its Clinical Candidate B244
    AOBiome Granted Composition of Matter Patent for its Clinical Candidate B244

    06 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aobiome-therapeutics-granted-composition-of-matter-patent-for-its-clinical-candidate-b244-301791237.html

    PR NEWSWIRE
    06 Apr 2023
    Share Share
    AOBiome reports positive Phase IIb data of topical atopic dermatitis asset
    AOBiome reports positive Phase IIb data of topical atopic dermatitis asset

    22 Feb 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/aobiome-b244-pruritus-eczema/

    CLINICALTRIALSARENA
    22 Feb 2022
    Share Share
    AOBiome Achieves Landmark Recruitment Goal in Largest Clinical Trial
    AOBiome Achieves Landmark Recruitment Goal in Largest Clinical Trial

    16 Nov 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/aobiome-achieves-landmark-recruitment-goal-in-largest-clinical-trial-ever-powered-by-a-live-topical-biotherapeutic-301424800.html

    PRNEWSWIRE
    16 Nov 2021
    Share Share
    AOBiome's New Shelf-Stable Formulation Of Its AOB Shows Reduction Of Itch Levels
    AOBiome's New Shelf-Stable Formulation Of Its AOB Shows Reduction Of Itch Levels

    17 Aug 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/new-30-patient-study-of-aobiomes-new-shelf-stable-formulation-of-its-ammonia-oxidizing-bacteria-aob-shows-reduction-of-itch-levels-in-both-pediatric-and-adult-subjects-who-suffer-from-eczema-301356425.html

    PRNEWSWIRE
    17 Aug 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search